drugset / Trial / NCT01305733

Local Infiltration Analgesia During Total Knee Arthroplasty

NCT01305733

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective is to evaluate whether local infiltration analgesia (LIA) will reduce oxycodone consumption during the first 48 postoperative hours in patients undergoing total knee arthroplasty (TKA).

Timeline

Start
2011-03
Primary completion
2012-05
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 0.5 mg
Comparator Ketorolac Other / unclassified 30 mg
Comparator Levobupivacaine Other / unclassified 150 mg

Indications

No indication recorded.